Overactive Bladder - Results from #2320

Evaluation of an experimental urodynamic platform to identify treatment effects: A randomized, placebo-controlled, crossover study in patients with overactive bladder - Abstract September 21, 2011

Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding - Abstract September 20, 2011

Feasibility of noninvasive near-infrared spectroscopy to diagnose detrusor overactivity - Abstract September 8, 2011

Responsiveness and minimal clinically important change in overactive bladder symptom score - Abstract September 7, 2011

Improved sexual and urinary function in women with sacral nerve stimulation - Abstract September 5, 2011

Inhibition of bladder overactivity by stimulation of feline pudendal nerve using transdermal amplitude-modulated signal (TAMS) - Abstract September 2, 2011

Simplifying the diagnosis of 4 common voiding conditions using uroflow/electromyography, electromyography lag time and voiding history - Abstract September 1, 2011

Urinary urgency: A review of its assessment as the key symptom of the overactive bladder syndrome - Abstract August 31, 2011

Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment - Abstract August 29, 2011

Overactive bladder in Taiwanese women: Re-analysis of epidemiological database of community from 1999 to 2001 - Abstract August 29, 2011

Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder - Abstract August 24, 2011

Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: Lack of anticholinergic efficacy versus intolerability - Abstract August 23, 2011

Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy - Abstract August 22, 2011

Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment - Abstract August 15, 2011

Non-invasive techniques in the diagnosis of bladder storage disorders - Abstract August 15, 2011

Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder - Abstract August 12, 2011

The overactive bladder - Abstract August 11, 2011

Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting - Abstract August 9, 2011

Surgical access for electrical stimulation of the pudendal and dorsal genital nerves in the overactive bladder: A review - Abstract August 5, 2011

Role of KIT-positive interstitial cells of Cajal in the urinary bladder and possible therapeutic target for overactive bladder - Abstract August 4, 2011

Page 117 of 122